Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4I2L5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 247 | 251 | PF00656 | 0.686 |
CLV_NRD_NRD_1 | 290 | 292 | PF00675 | 0.561 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.496 |
CLV_PCSK_KEX2_1 | 106 | 108 | PF00082 | 0.394 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.496 |
CLV_PCSK_PC1ET2_1 | 106 | 108 | PF00082 | 0.394 |
CLV_PCSK_PC1ET2_1 | 93 | 95 | PF00082 | 0.496 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.425 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 281 | 285 | PF00082 | 0.484 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.441 |
DEG_SPOP_SBC_1 | 172 | 176 | PF00917 | 0.787 |
DOC_CKS1_1 | 11 | 16 | PF01111 | 0.322 |
DOC_PP4_FxxP_1 | 116 | 119 | PF00568 | 0.635 |
DOC_USP7_MATH_1 | 173 | 177 | PF00917 | 0.758 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.704 |
DOC_USP7_MATH_1 | 248 | 252 | PF00917 | 0.751 |
DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.462 |
DOC_WW_Pin1_4 | 10 | 15 | PF00397 | 0.337 |
DOC_WW_Pin1_4 | 301 | 306 | PF00397 | 0.740 |
LIG_14-3-3_CanoR_1 | 171 | 181 | PF00244 | 0.698 |
LIG_14-3-3_CanoR_1 | 3 | 11 | PF00244 | 0.441 |
LIG_BIR_III_4 | 269 | 273 | PF00653 | 0.668 |
LIG_FHA_1 | 143 | 149 | PF00498 | 0.720 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.590 |
LIG_FHA_1 | 221 | 227 | PF00498 | 0.653 |
LIG_FHA_1 | 250 | 256 | PF00498 | 0.664 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.354 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.417 |
LIG_FHA_2 | 252 | 258 | PF00498 | 0.635 |
LIG_Integrin_RGD_1 | 277 | 279 | PF01839 | 0.495 |
LIG_IRF3_LxIS_1 | 146 | 151 | PF10401 | 0.678 |
LIG_LIR_Gen_1 | 205 | 215 | PF02991 | 0.636 |
LIG_LIR_Gen_1 | 257 | 267 | PF02991 | 0.652 |
LIG_LIR_Nem_3 | 163 | 168 | PF02991 | 0.723 |
LIG_LIR_Nem_3 | 205 | 211 | PF02991 | 0.604 |
LIG_LIR_Nem_3 | 257 | 263 | PF02991 | 0.601 |
LIG_SH2_CRK | 165 | 169 | PF00017 | 0.745 |
LIG_SH2_STAP1 | 208 | 212 | PF00017 | 0.661 |
LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.651 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.375 |
LIG_SH3_3 | 193 | 199 | PF00018 | 0.601 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.454 |
LIG_SH3_4 | 284 | 291 | PF00018 | 0.725 |
LIG_SUMO_SIM_anti_2 | 17 | 23 | PF11976 | 0.441 |
LIG_SUMO_SIM_anti_2 | 174 | 184 | PF11976 | 0.725 |
LIG_SUMO_SIM_anti_2 | 322 | 327 | PF11976 | 0.287 |
LIG_SUMO_SIM_par_1 | 144 | 151 | PF11976 | 0.697 |
LIG_SUMO_SIM_par_1 | 194 | 200 | PF11976 | 0.588 |
LIG_SUMO_SIM_par_1 | 223 | 231 | PF11976 | 0.649 |
LIG_SUMO_SIM_par_1 | 316 | 322 | PF11976 | 0.315 |
LIG_UBA3_1 | 211 | 216 | PF00899 | 0.657 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.732 |
MOD_CK1_1 | 200 | 206 | PF00069 | 0.645 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.663 |
MOD_CK1_1 | 251 | 257 | PF00069 | 0.671 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.468 |
MOD_CK1_1 | 293 | 299 | PF00069 | 0.753 |
MOD_CK2_1 | 174 | 180 | PF00069 | 0.760 |
MOD_CK2_1 | 253 | 259 | PF00069 | 0.659 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.470 |
MOD_CK2_1 | 293 | 299 | PF00069 | 0.745 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.416 |
MOD_Cter_Amidation | 104 | 107 | PF01082 | 0.498 |
MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.419 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.418 |
MOD_GlcNHglycan | 295 | 298 | PF01048 | 0.518 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.648 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.646 |
MOD_GSK3_1 | 217 | 224 | PF00069 | 0.621 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.410 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.646 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.332 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.339 |
MOD_N-GLC_1 | 142 | 147 | PF02516 | 0.374 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.663 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.708 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.655 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.354 |
MOD_PKA_2 | 221 | 227 | PF00069 | 0.608 |
MOD_PKA_2 | 273 | 279 | PF00069 | 0.669 |
MOD_PKA_2 | 290 | 296 | PF00069 | 0.749 |
MOD_Plk_1 | 142 | 148 | PF00069 | 0.684 |
MOD_Plk_2-3 | 253 | 259 | PF00069 | 0.677 |
MOD_Plk_2-3 | 50 | 56 | PF00069 | 0.416 |
MOD_Plk_4 | 17 | 23 | PF00069 | 0.386 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.647 |
MOD_Plk_4 | 207 | 213 | PF00069 | 0.577 |
MOD_ProDKin_1 | 10 | 16 | PF00069 | 0.340 |
MOD_ProDKin_1 | 301 | 307 | PF00069 | 0.736 |
TRG_DiLeu_BaLyEn_6 | 144 | 149 | PF01217 | 0.689 |
TRG_DiLeu_BaLyEn_6 | 222 | 227 | PF01217 | 0.707 |
TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.734 |
TRG_ENDOCYTIC_2 | 208 | 211 | PF00928 | 0.564 |
TRG_NLS_MonoExtN_4 | 289 | 295 | PF00514 | 0.716 |
TRG_Pf-PMV_PEXEL_1 | 95 | 99 | PF00026 | 0.440 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HX16 | Leptomonas seymouri | 42% | 95% |
A0A3Q8IE36 | Leishmania donovani | 99% | 100% |
A4HFE5 | Leishmania braziliensis | 73% | 100% |
C9ZKW5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 84% |
E9AD03 | Leishmania major | 91% | 100% |
E9AYS8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |